Home Newsfeeds Truist Securities Maintains Hold on Gilead Sciences, Raises Price Target to $76

Truist Securities Maintains Hold on Gilead Sciences, Raises Price Target to $76

Truist Securities analyst Robyn Karnauskas maintains Gilead Sciences (NASDAQ:GILD) with a Hold and raises the price target from $71 to $76.

byBenzinga Newsdesk

September 15, 2022

1 minute read

Truist Securities analyst Robyn Karnauskas maintains Gilead Sciences (NASDAQ:GILD) with a Hold and raises the price target from $71 to $76.

Lockheed Martin’s ‘Space Growth’ Sets Foundation For 2023 Upside, Credit Suisse Says

By Shivani Kumaresan

April 19, 12:52 PM

Credit Suisse analyst reiterated an Outperform rating on the shares of Lockheed Martin Corp (NYSE: LMT) and raised the price target from $510 to $550.

LMT

News

“Harley Davidson Recalls Thousands Of Motorcycles Over ‘Fatal’ Flaw” – Daily Mail

By Benzinga Newsdesk

September 19, 11:01 AM

https://www.dailymail.co.uk/news/article-12535487/Harley-Davidson-recall-fatal-flaw.htmlHarley Davidson Australia is recalling thousands of its motorbikes due to a fault which could have potentially fatal

HOG